SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
Chief Executive Officer Michael A Metzger sold $130K of Syndax Pharmaceuticals, Inc.
Sold$130,025
$18.99Price
6,847Shares
−1%Stake
What SNDX did after the filing
- The stock from Wed, Jun 3 open, $18.58
- +22.7%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Jul 17 close.
Traded Mon, Jun 1. Filed Tue, Jun 2, 4:30 PM ET, after the close. Returns use the Jun 3 open and the Jul 17 close. Not investment advice.